Intraday BUY SELL Signals
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
EUDG vs GSK
EUDG vs GSK Comparison
Open Charts EUDG vs GSK
EUDG vs GSK Comparison Chart in %
Loading...
loading
loading
View a ticker or compare two or three
VS
VS
EUDG vs. GSK commentary
Oct 03, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EUDG is a Hold and GSK is a Buy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 52 | |
SMR RATING 1..100 | 34 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 55 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EUDG | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 59% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 62% | 2 days ago 47% |
| MACD ODDS (%) | 4 days ago 73% | 2 days ago 43% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 54% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 53% |
| Advances ODDS (%) | 8 days ago 79% | 16 days ago 64% |
| Declines ODDS (%) | 2 days ago 75% | 2 days ago 55% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 57% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 42% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
EUDG and
Correlation & Price change
A.I.dvisor tells us that EUDG and FOUR have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EUDG and FOUR's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EUDG | 1D Price Change % | ||
|---|---|---|---|---|
| EUDG | 100% | -1.38% | ||
| FOUR - EUDG | 22% Poorly correlated | -1.63% | ||
| NEM - EUDG | 19% Poorly correlated | -0.58% | ||
| OR - EUDG | 19% Poorly correlated | -1.05% | ||
| MC - EUDG | 16% Poorly correlated | -0.99% | ||
| GSK - EUDG | 16% Poorly correlated | -2.06% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y